DASFREE: Treatment-free remission (TFR) after discontinuation of dasatinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) and deep molecular response (DMR) Meeting Abstract


Authors: Shah, N. P.; Garcia-Gutiérrez, V.; Jiménez-Velasco, A.; Larson, S.; Saussele, S.; Rea, D.; Mahon, F. X.; Levy, M. Y.; Gómez-Casares, M. T.; Luciano, L.; Nicolini, F. E.; Mauro, M. J.; Sy, O.; Martin-Regueira, P.; Lipton, J. H.
Abstract Title: DASFREE: Treatment-free remission (TFR) after discontinuation of dasatinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) and deep molecular response (DMR)
Meeting Title: 7th Annual Meeting of the Society of Hematologic Oncology (SOHO 2019)
Keywords: imatinib; cml; dasatinib; chronic; myelogenous leukemia; treatment-free remission; cml-cp
Journal Title: Clinical Lymphoma, Myeloma and Leukemia
Volume: 19
Issue: Suppl. 1
Meeting Dates: 2019 Sep 11-14
Meeting Location: Houston, TX
ISSN: 2152-2650
Publisher: Elsevier Inc.  
Date Published: 2019-09-01
Start Page: S299
Language: English
ACCESSION: WOS:000483480700290
DOI: 10.1016/j.clml.2019.07.253
PROVIDER: wos
Notes: Meeting Abstract: CML-283 -- Source: Wos
Altmetric Score
MSK Authors
  1. Michael John Mauro
    134 Mauro